Canaan (CAN) Research & Development (2018 - 2026)

Canaan (CAN) has reported Research & Development for 9 consecutive years, with -$15.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 18.77% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$59.6 million (up 8.22% YoY), while the FY2025 annual figure was $13.6 million, up 138.0% from the prior year.
• Research & Development fell to -$15.4 million in Q1 2026 per CAN's latest filing, from -$11.5 million in the prior quarter.
• Across five years, Research & Development topped out at -$10.8 million in Q4 2023 and bottomed at -$33.4 million in Q4 2022.
• Historically, Research & Development has averaged -$16.9 million across 5 years, with a median of -$16.3 million in 2025.
• Annual changes were most pronounced in 2022 — Research & Development slumped 89.81% — and 2023, when it jumped 67.7%.
• Canaan's Research & Development stood at -$33.4 million in 2022, then surged by 67.7% to -$10.8 million in 2023, then slumped by 53.76% to -$16.6 million in 2024, then jumped by 30.87% to -$11.5 million in 2025, then tumbled by 34.34% to -$15.4 million in 2026.
• Business Quant data shows CAN's Research & Development at -$15.4 million in Q1 2026, -$11.5 million in Q4 2025, and -$16.3 million in Q3 2025.